Opportunities and challenges for innovative and equitable healthcare

David J. Ecker, Clarice D. Aiello, Joseph R. Arron, C. Frank Bennett, Amy Bernard, Xandra O. Breakefield, Timothy J. Broderick, Shawneequa L. Callier, Barry Canton, Janice S. Chen, C. Simone Fishburn, Banning Garrett, Sidney M. Hecht, Tobias Janowitz, Melinda Kliegman, Adrian Krainer, Chrystal U. Louis, Christopher Lowe, Alfica Sehgal, Yesim TozanKevin J. Tracey, Fyodor Urnov, Daniel Wattendorf, Thomas W. Williams, Xuanhe Zhao, Michael R. Hayden

Research output: Contribution to journalComment/debatepeer-review


An unprecedented number of potentially disruptive therapeutic technologies are under development. Forward-looking policies, incentives and infrastructure are needed to harness these advances to provide effective and globally equitable healthcare.

Original languageEnglish (US)
Pages (from-to)321-322
Number of pages2
JournalNature Reviews Drug Discovery
Issue number5
StatePublished - May 2024

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Opportunities and challenges for innovative and equitable healthcare'. Together they form a unique fingerprint.

Cite this